Safety study of TL-003 for healthy adults and ulcerative colitis
This is an early-stage study testing a new drug called TL-003 to see if it's safe and how the body processes it. Researchers will first test it in healthy volunteers, then in people with ulcerative colitis (an inflammatory bowel disease) to understand if it might help reduce inflammation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 55 years old with a healthy weight (BMI 18–32)
- Have no major organ disease, immune system problems, or kidney/liver issues based on blood tests
- Not have had recent major surgery, cancer, tuberculosis, or HIV/hepatitis
- Not be pregnant, breastfeeding, or unwilling to use reliable contraception during the study
- Not take most prescription medications, recreational drugs, or smoke heavily
- Not have had recent serious infections or be currently taking antibiotics
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug, TL-001, in healthy volunteers to see if it is safe and how the body processes it. You may join if you are a healthy adult between 18 and 55.
This Phase 1 trial tests a new drug called LMT503 in adults to learn its safety, tolerability, and how the body handles it. If you qualify, you may receive the study medicine in a controlled research setting with regular checkups and blood/heart monitoring.
This trial tests a new medicine called HL-003 in healthy people to see if it is safe and how the body processes it. You may join if you are generally healthy, between 18 and 50 years old, and meet specific health and lifestyle requirements.
This trial tests a new medicine to see if it's safe for people with moderate to severe ulcerative colitis. It also tests the medicine in healthy volunteers to check for side effects. If you have ulcerative colitis, this might offer a new treatment option.
This study tests an investigational oral drug for ulcerative colitis. It is an early-stage trial to check safety and how the drug is processed by the body in both healthy volunteers and patients with active ulcerative colitis.
This study tests a new drug called ATH-063 to see if it can help people with moderate-to-severe ulcerative colitis (a condition causing inflammation and bleeding in the colon) who haven't responded well to previous biologic treatments. The goal is to find out if this new drug is safe and effective.
Hear when a new Healthy Volunteer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.